- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 01.09. | Vivos Therapeutics, Inc.: Vivos Therapeutics to Present at the 2026 Moody Capital Solutions Disruptive Growth & Life Sciences Conference | 773 | Newsfile | Littleton, Colorado--(Newsfile Corp. - September 1, 2026) - Vivos Therapeutics, Inc. (NASDAQ: VVOS) ("Vivos" or the "Company"), a leading medical technology and healthcare services company focused on... ► Artikel lesen | |
| 28.08. | Vivos Therapeutics, Inc: Vivos Therapeutics and South Palm Cardiovascular Associates Sign Definitive Agreements to Launch Regional Sleep Testing and Treatment Center | 6 | GlobeNewswire (USA) | ||
| 25.08. | Vivos Therapeutics, Inc: Vivos Therapeutics Reports Record New Patient Referrals at its Nevada Sleep & Airway Medicine Centers | 1 | GlobeNewswire (USA) | ||
| 21.08. | Vivos Therapeutics, Inc. - 8-K, Current Report | 3 | SEC Filings | ||
| 20.08. | Vivos Therapeutics opens Henderson facility with $10M capacity | 1 | Investing.com | ||
| VIVOS THERAPEUTICS Aktie jetzt für 0€ handeln | |||||
| 20.08. | Vivos Therapeutics, Inc: Vivos Therapeutics Opens New Sleep Testing and Treatment Facility in Nevada to Meet Rapidly Growing Patient Demand for Sleep Apnea Testing and Treatment | 1 | GlobeNewswire (USA) | ||
| 18.08. | Vivos Therapeutics: Service Revenue Nearly Doubles To $3.8 Million While Product Revenue Falls 28% | 4 | pulse2.com | ||
| 17.08. | Vivos Therapeutics GAAP EPS of -$0.31 misses by $0.01, revenue of $5.15M misses by $0.99M | 1 | Seeking Alpha | ||
| 15.08. | Vivos Therapeutics Reports Q2 2026 Results: Full Earnings Call Transcript | 2 | Benzinga.com | ||
| 14.08. | Vivos Therapeutics steigert Umsatz im zweiten Quartal 2026 um 35 % | 1 | Investing.com Deutsch | ||
| 14.08. | Vivos Therapeutics reports 35% revenue increase in Q2 2026 | 2 | Investing.com | ||
| 14.08. | Vivos Therapeutics, Inc: Vivos Therapeutics Reports Second Quarter 2026 Financial Results and Provides Operational Update | 279 | GlobeNewswire (Europe) | Quarter highlighted by steadily increasing patient demand for Vivos' differentiated array of highly effective OSA treatments Management to Host Conference Call today at 5:00 pm ET LITTLETON, Colo.... ► Artikel lesen | |
| 11.08. | Vivos Therapeutics, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 11.08. | Vivos Therapeutics, Inc: Vivos Therapeutics Expands Greenway Health Partnership to Deploy AI-Enabled Platform Across All Clinical and Revenue Operations | 3 | GlobeNewswire (USA) | ||
| 05.08. | Vivos Therapeutics, Inc: Vivos Therapeutics Announces Issuance of New US Patent Broadening Protection for Its Vivos CARE Oral Medical Device Technology | 367 | GlobeNewswire (Europe) | LITTLETON, Colo., Aug. 05, 2026 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. ("Vivos" or "the Company") (NASDAQ: VVOS), a leading medical device and healthcare services company focused on developing... ► Artikel lesen | |
| 03.08. | Vivos Therapeutics, Inc. - 8-K, Current Report | 20 | SEC Filings | ||
| 07.07. | Vivos Therapeutics, Inc. - 8-K, Current Report | 5 | SEC Filings | ||
| 30.06. | Vivos Therapeutics, Inc: Vivos' Vida Appliance Shows Statistically Significant Improvement in Insomnia Severity in 100% of Study Participants | 14 | GlobeNewswire (USA) | ||
| 25.06. | Vivos Therapeutics, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 22.06. | Vivos Therapeutics, Inc: Vivos Therapeutics and Streeterville Extend Timeframe of Strategic Financing Agreement and Reaffirm Commitment to Convert Debt Into Common Stock and Perpetual Preferred Equity | 289 | GlobeNewswire (Europe) | LITTLETON, Colo., June 22, 2026 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. ("Vivos" or the "Company") (NASDAQ: VVOS), a leading medical device and healthcare services company focused on the treatment... ► Artikel lesen |
1 2 3 Weiter >>
55 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ECKERT & ZIEGLER | 12,170 | -1,54 % | EQS-PVR: Eckert & Ziegler SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution | EQS Voting Rights Announcement: Eckert & Ziegler SE
Eckert & Ziegler SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective... ► Artikel lesen | |
| TELADOC HEALTH | 5,422 | +0,78 % | Teladoc Health, Inc.: Teladoc Health Appoints Financial Executive Mark Anquillare to Its Board of Directors | NEW YORK, Aug. 03, 2026 (GLOBE NEWSWIRE) -- Teladoc Health (NYSE: TDOC), the global leader in virtual care, today announced the appointment of Mark V. Anquillare to its board of directors. Mr. Anquillare... ► Artikel lesen | |
| SERNOVA BIOTHERAPEUTICS | 0,062 | -3,11 % | Dr. Steven S. Sangha: Steven Sangha Announces Voting and Support Agreement for Sernova Biotherapeutics Inc.'s Proposed Business Combination with Seraxis Holdings, Inc. | Toronto, Ontario--(Newsfile Corp. - September 11, 2026) - Steven Sangha announces he has entered into a voting and support agreement ("Voting Agreement") with Seraxis Holdings, Inc. ("Seraxis") in connection... ► Artikel lesen | |
| SYNLAB | - | - | EQS-News: SYNLAB: Synnovis and Apian partner to advance drone and autonomous robotics in healthcare logistics | EQS-News: SYNLAB
/ Key word(s): Miscellaneous
Synnovis and Apian partner to advance drone and autonomous robotics in healthcare logistics
07.09.2026 / 09:31 CET/CEST
The... ► Artikel lesen | |
| CERENOME | 1,616 | -3,46 % | CNSide Diagnostics signs agreement with Blue Cross Michigan | ||
| NUGEN MEDICAL DEVICES | 0,011 | -100,00 % | NuGen Medical Devices Inc.: NuGen Announces Loan Agreement with Sol-Millennium Medical HK Limited | Toronto, Ontario--(Newsfile Corp. - September 21, 2026) - NuGen Medical Devices Inc. (TSXV: NGMD) ("NuGen" or the "Company") is pleased to announce the entering into of a loan agreement (the "Loan Agreement")... ► Artikel lesen | |
| CARDINAL HEALTH | 193,00 | -0,69 % | Cardinal Health (NYSE:CAH) Vs Danaher Corporation (NYSE:DHR) - Here's The One Jim Cramer Said Did Better | ||
| ATOSSA THERAPEUTICS | 1,890 | -2,58 % | ATOSSA THERAPEUTICS, INC. - 8-K, Current Report | ||
| INVITAE | - | - | Patentstreit: Natera sichert sich 30 % Lizenzgebühr von Invitae | ||
| SONOMA PHARMACEUTICALS | 2,350 | -100,00 % | Sonoma Pharmaceuticals: Historischer Wendepunkt - darum fliegt die Aktie! | Volltreffer: Bereits im Frühjahr hatte ich die positive Entwicklung bei Sonoma Pharmaceuticals antizipiert und die Nano-Cap-Aktie als hochinteressante Turnaround-Spekulation vorgestellt. Damals hatte... ► Artikel lesen | |
| EVOFEM BIOSCIENCES | - | - | Evofem Biosciences, Inc. - 8-K, Current Report | ||
| SIEMENS HEALTHINEERS | 37,210 | +0,03 % | EQS-News: CPT GmbH: Warren Wise scannt Siemens Healthineers: Scharfe Bilder für Ärzte, unscharfe für Investoren | EQS-News: CPT GmbH
/ Schlagwort(e): Research Update/Jahresbericht
Warren Wise scannt Siemens Healthineers: Scharfe Bilder für Ärzte, unscharfe für Investoren
18.09.2026... ► Artikel lesen | |
| FRESENIUS | 45,735 | -1,09 % | EQS-News: mAbxience und Sandoz unterzeichnen Kooperationsvereinbarung zur weltweiten Förderung des Zugangs zu Biosimilars | EQS-News: mAbxience
/ Schlagwort(e): Vereinbarung/Sonstiges
mAbxience und Sandoz unterzeichnen Kooperationsvereinbarung zur weltweiten Förderung des Zugangs zu Biosimilars
19.09.2026... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 39,350 | -0,63 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 7,680 | +0,13 % | Alignment Healthcare Reports Second Quarter 2026 Results, Surpassing High End of Guidance Across All Key Metrics | Generates $1.3 billion in total revenue, representing 31.6% growth year-over-year Grows Medicare Advantage membership 31.5% year-over-year to approximately 294,100 membersRaises the midpoint of all... ► Artikel lesen |
VIVOS THERAPEUTICS INC gehört der Branche Gesundheitswesen an. Die relative Kursveränderung beträgt aktuell 0,00 % bei einem Aktienkurs von 0,147 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu VIVOS THERAPEUTICS INC finden Sie auf Wallstreet Online.